Anterix Inc. $ATEX Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP boosted its stake in Anterix Inc. (NASDAQ:ATEXFree Report) by 64.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,619 shares of the company’s stock after acquiring an additional 6,132 shares during the period. Quantinno Capital Management LP owned about 0.08% of Anterix worth $596,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. GSA Capital Partners LLP boosted its position in shares of Anterix by 22.3% in the 4th quarter. GSA Capital Partners LLP now owns 72,976 shares of the company’s stock valued at $1,593,000 after purchasing an additional 13,324 shares during the period. Waterfront Wealth Inc. increased its position in Anterix by 23.3% during the first quarter. Waterfront Wealth Inc. now owns 59,955 shares of the company’s stock worth $2,290,000 after buying an additional 11,328 shares during the period. Kirr Marbach & Co. LLC IN lifted its stake in Anterix by 13.3% in the first quarter. Kirr Marbach & Co. LLC IN now owns 113,814 shares of the company’s stock valued at $4,347,000 after buying an additional 13,396 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Anterix by 30.8% in the first quarter. Dimensional Fund Advisors LP now owns 424,856 shares of the company’s stock valued at $16,223,000 after buying an additional 99,933 shares during the last quarter. Finally, Inspire Investing LLC acquired a new stake in shares of Anterix in the first quarter valued at approximately $508,000. Hedge funds and other institutional investors own 87.67% of the company’s stock.

Anterix Price Performance

NASDAQ:ATEX opened at $88.68 on Thursday. The firm’s fifty day moving average price is $94.07 and its 200 day moving average price is $61.75. Anterix Inc. has a 1-year low of $17.58 and a 1-year high of $113.00. The firm has a market cap of $1.74 billion, a price-to-earnings ratio of 25.34 and a beta of 0.85.

Anterix (NASDAQ:ATEXGet Free Report) last announced its quarterly earnings data on Tuesday, August 11th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.43) by $0.44. Anterix had a net margin of 933.03% and a negative return on equity of 10.65%. The company had revenue of $1.96 million for the quarter, compared to analysts’ expectations of $2.00 million. As a group, analysts expect that Anterix Inc. will post -2 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. lowered their target price on shares of Anterix from $133.00 to $130.00 and set an “overweight” rating on the stock in a research report on Thursday, August 13th. Weiss Ratings upgraded shares of Anterix from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 26th. Clear Str upgraded shares of Anterix to a “strong-buy” rating in a research note on Monday, July 27th. Wall Street Zen downgraded shares of Anterix from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Finally, B. Riley Financial lowered shares of Anterix from a “buy” rating to a “neutral” rating and lifted their price objective for the company from $44.00 to $69.00 in a research note on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Anterix presently has a consensus rating of “Moderate Buy” and a consensus price target of $99.50.

Check Out Our Latest Research Report on Anterix

Insider Buying and Selling at Anterix

In related news, insider Christopher Guttman-Mccabe sold 91,437 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $82.46, for a total transaction of $7,539,895.02. Following the completion of the transaction, the insider directly owned 77,807 shares of the company’s stock, valued at $6,415,965.22. This represents a 54.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director William Heard sold 46,400 shares of the stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $90.11, for a total transaction of $4,181,104.00. Following the transaction, the director directly owned 1,670,338 shares of the company’s stock, valued at $150,514,157.18. This represents a 2.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 170,509 shares of company stock valued at $14,355,262. Insiders own 40.05% of the company’s stock.

About Anterix

(Free Report)

Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.

At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.

Read More

Want to see what other hedge funds are holding ATEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anterix Inc. (NASDAQ:ATEXFree Report).

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.